Brain scan surveillance trial launches for High-Risk breast cancer patients
NCT ID NCT07503717
First seen Apr 14, 2026 · Last updated Apr 28, 2026 · Updated 2 times
Summary
This study looks at whether regular brain MRI scans can find cancer that has spread to the brain before symptoms start in people with HER2-positive metastatic breast cancer. About 69 participants will be randomly assigned to either routine brain scans or standard care (no routine scans). The main goal is to see if enough patients are willing to join and be randomized, not yet to prove that surveillance improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beaumont RCSI Cancer Centre
RECRUITINGBeaumont, Ireland
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.